SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-112508
Filing Date
2016-07-12
Accepted
2016-07-12 08:30:40
Documents
23
Period of Report
2016-07-12

Document Format Files

Seq Description Document Type Size
1 6-K v444082_6k.htm 6-K 13251
2 EXHIBIT 99.1 v444082_ex99-1.htm EX-99.1 27317
3 GRAPHIC image_001.jpg GRAPHIC 22759
4 GRAPHIC image_002.jpg GRAPHIC 227819
5 GRAPHIC image_003.jpg GRAPHIC 119254
6 GRAPHIC image_004.jpg GRAPHIC 62917
7 GRAPHIC image_005.jpg GRAPHIC 93788
8 GRAPHIC image_006.jpg GRAPHIC 127921
9 GRAPHIC image_007.jpg GRAPHIC 89481
10 GRAPHIC image_008.jpg GRAPHIC 93586
11 GRAPHIC image_009.jpg GRAPHIC 97370
12 GRAPHIC image_010.jpg GRAPHIC 87606
13 GRAPHIC image_011.jpg GRAPHIC 101759
14 GRAPHIC image_012.jpg GRAPHIC 83058
15 GRAPHIC image_013.jpg GRAPHIC 86518
16 GRAPHIC image_014.jpg GRAPHIC 89682
17 GRAPHIC image_015.jpg GRAPHIC 86155
18 GRAPHIC image_016.jpg GRAPHIC 106705
19 GRAPHIC image_017.jpg GRAPHIC 82938
20 GRAPHIC image_018.jpg GRAPHIC 46052
21 GRAPHIC image_019.jpg GRAPHIC 117095
22 GRAPHIC image_020.jpg GRAPHIC 87922
23 GRAPHIC image_021.jpg GRAPHIC 22759
  Complete submission text file 0001144204-16-112508.txt   2702268
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 161763186
SIC: 2834 Pharmaceutical Preparations